Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 35 clinical trials
Effects of Dietary Folate and Phytate Zinc Absorption: Zinc Amino Acid Complexes vs. Zinc-chloride

The purpose of this study is to determine the effects of consuming a small breakfast of juice and toast with added phytate or with taking a folic acid supplement on the absorption of a small amount of zinc that is either bound to amino acids or to chloride or picolinate. …

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
Effect of Preoperative Intervention With Folic Acid and Vitamin B12 on Postoperative Neurobehavioral Changes in Children

Comparison of preoperative folic acid and VitB12 intervention on postoperative delirium and long-term neurobehavioral changes in children under general anesthesia

anesthesia
postoperative delirium
  • 0 views
  • 24 Jan, 2021
  • 1 location
PSMA PET and MRI in Gynecological Cancers

The goal of this research is to determine the accuracy of PSMA positron emission tomography (PET) and multi-parametric magnetic resonance (MR) imaging to detect the presence of gynecological cancer cells in the body.

Accepts healthy volunteers
cancer
  • 0 views
  • 29 May, 2022
  • 1 location
Returning Genetic Results on Arsenic Susceptibility

In recent years, returning genetic results to research participants has become a topic of debate, with a growing consensus that researchers should offer to return incidental findings and research results to participants. Currently, the research and debates surrounding return of results (ROR) have primarily taken place in high-income countries. Less …

Accepts healthy volunteers
  • 0 views
  • 03 Nov, 2021
  • 1 location
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO)

, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.

cancer of the ovary
mirvetuximab soravtansine
ovarian cancer
fallopian tube
  • 17 views
  • 25 Oct, 2022
  • 68 locations
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (MIRASOL)

next line of therapy. Folate receptor alpha (FRα) positivity will be defined by the Ventana FOLR1 (FOLR1-2.1) CDx assay.

cytotoxic chemotherapy
topotecan
fallopian tube
cancer antigen 125
antineoplastic
  • 124 views
  • 01 Jul, 2022
  • 163 locations
Nutri-CAP: Nutrition for Children, Adolescent Girls, and Pregnant Women in Slums of Dhaka City

adolescent girls, and ensuring proper physical growth of under 2 children. Hypothesis Pregnant Women: Intensive nutrition and WASH counseling, iron-folate, calcium supplementation

Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2022
  • 1 location
PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

in vivo. PSMA is a homodimeric type II membrane metalloenzyme that functions as a glutamate carboxypeptidase/folate hydrolase and is overexpressed in PCa. PSMA is expressed in the vast majority of

pet/ct scan
metastatic prostate cancer
aggressiveness
prostate cancer metastatic
bone scan
  • 0 views
  • 04 Oct, 2022
  • 1 location
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer (MIROVA)

This is a multi-center, randomized, two-arm, open-label, comparative phase II trial of Mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα) high recurrent ovarian cancer eligible

  • 0 views
  • 08 Jul, 2022
  • 7 locations
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial cancers that overexpress folate receptor

mirvetuximab soravtansine
endometrial adenocarcinoma
recurrent endometrial cancer
recurrent disease
carcinoma
  • 4 views
  • 04 Oct, 2022
  • 1 location